CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA (0MSD.L) Financial Performance & Income Statement Overview
Review CompuGroup Medical SE & Co. KGaA (0MSD.L) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
CompuGroup Medical SE & Co. KGaA (0MSD.L) Income Statement & Financial Overview
View the income breakdown for CompuGroup Medical SE & Co. KGaA 0MSD.L across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $286.16M | $308.69M | $283.44M | $277.23M |
| Cost of Revenue | $44.38M | $54.31M | $45.29M | $190.38M |
| Gross Profit | $241.78M | $254.38M | $238.15M | $86.85M |
| Gross Profit Ratio | $0.84 | $0.82 | $0.84 | $0.31 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | -$4.52M |
| Operating Expenses | $219.46M | $219.67M | $217.15M | $8.49M |
| Total Costs & Expenses | $263.84M | $273.98M | $262.44M | $198.86M |
| Interest Income | $3.35M | $78000.00 | $0.00 | $203000.00 |
| Interest Expense | $8.61M | $2.71M | $14.48M | $7.88M |
| Depreciation & Amortization | $27.16M | $29.35M | $27.33M | $28.45M |
| EBITDA | $51.54M | $35.68M | $54.09M | $56.07M |
| EBITDA Ratio | $0.18 | $0.12 | $0.19 | $0.20 |
| Operating Income | $22.32M | $34.71M | $21.005M | $86.76M |
| Operating Income Ratio | $0.08 | $0.11 | $0.07 | $0.31 |
| Other Income/Expenses (Net) | -$6.54M | -$31.10M | -$8.73M | -$67.02M |
| Income Before Tax | $15.78M | $3.61M | $12.27M | $19.73M |
| Income Before Tax Ratio | $0.06 | $0.01 | $0.04 | $0.07 |
| Income Tax Expense | $4.73M | $9.65M | $3.68M | $5.92M |
| Net Income | $10.92M | -$6.47M | $8.62M | $13.93M |
| Net Income Ratio | $0.04 | -$0.02 | $0.03 | $0.05 |
| EPS | $0.21 | -$0.13 | $0.17 | $0.34 |
| Diluted EPS | $0.21 | -$0.12 | $0.16 | $0.34 |
| Weighted Avg Shares Outstanding | $51.73M | $51.73M | $51.71M | $51.71M |
| Weighted Avg Shares Outstanding (Diluted) | $52.78M | $52.78M | $52.43M | $51.71M |
Over the last four quarters, CompuGroup Medical SE & Co. KGaA's revenue moved from $277.23M in Q2 2024 to $286.16M in Q1 2025. Operating income in Q1 2025 was $22.32M, with a strong operating margin of 8%. Despite fluctuations in R&D and SG&A expenses, EBITDA for CompuGroup Medical SE & Co. KGaA remained robust at $51.54M, reflecting operational efficiency. Net income rose to $10.92M, with an EPS of $0.21. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan